{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T03:22:44Z","timestamp":1790652164858,"version":"4.1.0"},"publisher-location":"Berlin\/Heidelberg","reference-count":110,"publisher":"Springer-Verlag","isbn-type":[{"value":"3540258752","type":"print"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1007\/3-540-29717-0_9","type":"book-chapter","created":{"date-parts":[[2005,12,28]],"date-time":"2005-12-28T02:55:44Z","timestamp":1135738544000},"page":"199-219","source":"Crossref","is-referenced-by-count":33,"title":["Protein Aggregation as a Cause for Disease"],"prefix":"10.1007","author":[{"given":"T.","family":"Scheibel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Buchner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"9_CR1","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1126\/science.1087348","volume":"302","author":"A. Aguzzi","year":"2003","unstructured":"Aguzzi A, Haass C (2003) Games played by rogue proteins in prion disorders and Alzheimer\u2019s disease. Science 302:814\u2013818","journal-title":"Science"},{"key":"9_CR2","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S0079-6123(03)46014-7","volume":"146","author":"J. Alberch","year":"2004","unstructured":"Alberch J, Perez-Navarro E, Canals JM (2004) Neurotrophic factors in Huntington\u2019s disease. Prog Brain Res 146:195\u2013229","journal-title":"Prog Brain Res"},{"key":"9_CR3","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S0014-5793(00)01676-8","volume":"476","author":"J. Avila","year":"2000","unstructured":"Avila J (2000) Tau aggregation into fibrillar polymers: taupathies. FEBS Lett 476:89\u201392","journal-title":"FEBS Lett"},{"key":"9_CR4","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1016\/S0140-6736(03)13304-1","volume":"361","author":"G. Bates","year":"2003","unstructured":"Bates G (2003) Huntingtin aggregation and toxicity in Huntington\u2019s disease. Lancet 361:1642\u20131644","journal-title":"Lancet"},{"key":"9_CR5","first-page":"245","volume":"379","author":"M. Beissinger","year":"1998","unstructured":"Beissinger M, Buchner J (1998) How chaperones fold proteins. Biol Chem. 379:245\u2013259","journal-title":"Biol Chem."},{"key":"9_CR6","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1126\/science.292.5521.1552","volume":"292","author":"N.F. Bence","year":"2001","unstructured":"Bence NF, Sampat RM, Kopito RR (2001) Impairment of the ubiquitin-proteasome system by protein aggregation. Science 292:1552\u20131555","journal-title":"Science"},{"key":"9_CR7","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S0959-437X(03)00053-4","volume":"13","author":"S.J. Berke","year":"2003","unstructured":"Berke SJ, Paulson HL (2003) Protein aggregation and the ubiquitin proteasome pathway: gaining the UPPer hand on neurodegeneration. Curr Opin Genet Dev 13:253\u2013261","journal-title":"Curr Opin Genet Dev"},{"key":"9_CR8","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/12043","volume":"1","author":"B.C. Braun","year":"1999","unstructured":"Braun BC, Glickman M, Kraft R et al (1999) The base of the proteasome regulatory particle exhibits chaperone-like activity. Nat Cell Biol 1:221\u2013226","journal-title":"Nat Cell Biol"},{"key":"9_CR9","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/73098","volume":"6","author":"M.E. Bruce","year":"2000","unstructured":"Bruce ME (2000) \u2018New variant\u2019 Creutzfeldt-Jakob disease and bovine spongiform encephalopathy. Nat Med 6:258\u2013259","journal-title":"Nat Med"},{"key":"9_CR10","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1750-3639.1995.tb00625.x","volume":"5","author":"H. Budka","year":"1995","unstructured":"Budka H, Aguzzi A, Brown P, et al (1995) Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases). Brain Pathol 5:459\u2013466","journal-title":"Brain Pathol"},{"key":"9_CR11","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S0092-8674(00)80928-9","volume":"92","author":"B. Bukau","year":"1998","unstructured":"Bukau B, Horwich AL (1998) The Hsp70 and Hsp60 chaperone machines. Cell 92:351\u2013366","journal-title":"Cell"},{"key":"9_CR12","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/S0047-6374(01)00249-4","volume":"122","author":"D.A. Butterfield","year":"2001","unstructured":"Butterfield DA, Kanski J (2001) Brain protein oxidation in age-related neurodegenerative disorders that are associated with aggregated proteins. Mech Aging Dev 122:945\u2013962","journal-title":"Mech Aging Dev"},{"key":"9_CR13","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/S0140-6736(97)02073-4","volume":"350","author":"R.W. Carrell","year":"1997","unstructured":"Carrell RW, Lomas DA (1997) Conformational disease. Lancet 350:134\u2013138","journal-title":"Lancet"},{"key":"9_CR14","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1056\/NEJMra010772","volume":"346","author":"R.W. Carrell","year":"2002","unstructured":"Carrell RW, Lomas DA (2002) Alpha1-antitrypsin deficiency: a model for conformational diseases. N Engl J Med 346:45\u201353","journal-title":"N Engl J Med"},{"key":"9_CR15","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1146\/annurev.neuro.26.010302.081142","volume":"26","author":"B. Caughey","year":"2003","unstructured":"Caughey B, Lansbury PT (2003) Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates fromthe innocent bystanders. Annu RevNeurosci 26:267\u2013298","journal-title":"Annu RevNeurosci"},{"key":"9_CR16","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/S0959-440X(99)00048-2","volume":"10","author":"J.I. Clark","year":"2000","unstructured":"Clark JI, Muchowski PJ (2000) Small heat-shock proteins and their potential role in human disease. Curr Opin Struct Biol 10:52\u201359","journal-title":"Curr Opin Struct Biol"},{"key":"9_CR17","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/S0140-6736(99)05128-4","volume":"354","author":"J. Collinge","year":"1999","unstructured":"Collinge J (1999) Variant Creutzfeldt-Jakob disease. Lancet 354:317\u2013323","journal-title":"Lancet"},{"key":"9_CR18","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1146\/annurev.neuro.24.1.519","volume":"24","author":"J. Collinge","year":"2001","unstructured":"Collinge J (2001) Prion diseases of humans and animals: their causes and molecular basis. Annu Rev Neurosci 24:519\u2013550","journal-title":"Annu Rev Neurosci"},{"key":"9_CR19","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1006\/jsbi.2000.4273","volume":"130","author":"A.M. Damas","year":"2000","unstructured":"Damas AM, Saraiva MJ (2000) Review: TTR amyloidosis-structural features leading to protein aggregation and their implications on therapeutic strategies. J Struct Biol 130:290\u2013299","journal-title":"J Struct Biol"},{"key":"9_CR20","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1172\/JCI200317575","volume":"111","author":"T.M. Dawson","year":"2003","unstructured":"Dawson TM, Dawson VL (2003) Rare genetic mutations shed light on the pathogenesis of Parkinson disease. J Clin Invest 111:145\u2013151","journal-title":"J Clin Invest"},{"key":"9_CR21","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1021\/ar00036a002","volume":"26","author":"L.R. Deyoung","year":"1993","unstructured":"Deyoung LR, Fink AL, Dill KA (1993) Aggregation of globular proteins. Acc Chem Res 26:614\u2013620","journal-title":"Acc Chem Res"},{"key":"9_CR22","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0197-4580(95)00013-5","volume":"16","author":"D.W. Dickson","year":"1995","unstructured":"Dickson DW, Crystal HA, Bevona C et al (1995) Correlations of synaptic and pathological markers with cognition of the elderly. Neurobiol Aging 16:285\u2013298","journal-title":"Neurobiol Aging"},{"key":"9_CR23","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1098\/rstb.2000.0758","volume":"356","author":"C.M. Dobson","year":"2001","unstructured":"Dobson CM (2001) The structural basis of protein folding and its links with human disease. Philos Trans R Soc Lond B Biol Sci 356:133\u2013145","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"9_CR24","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.semcdb.2003.12.008","volume":"15","author":"C.M. Dobson","year":"2004","unstructured":"Dobson CM (2004) Principles of protein folding, misfolding and aggregation. Semin Cell Dev Biol 15:3\u201316","journal-title":"Semin Cell Dev Biol"},{"key":"9_CR25","doi-asserted-by":"publisher","first-page":"5746","DOI":"10.1073\/pnas.100422497","volume":"97","author":"S. Dukan","year":"2000","unstructured":"Dukan S, Farewell A, Ballestros M et al (2000) Protein oxidation in response to increased transcriptional or translational errors. Proc. Natl Acad Sci U S A 97:5746\u20135749","journal-title":"Proc. Natl Acad Sci U S A"},{"key":"9_CR26","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1177\/16.11.673","volume":"16","author":"E.D. Eanes","year":"1968","unstructured":"Eanes ED, Glenner GG (1968) X-ray diffraction studies on amyloid filaments. J Histochem Cytochem 16: 673\u2013677","journal-title":"J Histochem Cytochem"},{"key":"9_CR27","doi-asserted-by":"publisher","first-page":"R9","DOI":"10.1016\/S1359-0278(98)00005-4","volume":"3","author":"A.L. Fink","year":"1998","unstructured":"Fink AL (1998) Protein aggregation: folding aggregates, inclusion bodies and amyloid. Fold Des 3:R9\u2013R23","journal-title":"Fold Des"},{"key":"9_CR28","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0197-4580(02)00076-3","volume":"23","author":"G. Forloni","year":"2002","unstructured":"Forloni G, Terreni L, Bertani I et al (2002) Protein misfolding in Alzheimer\u2019s and Parkinson\u2019s disease: genetics and molecular mechanisms. Neurobiol Aging 23:957\u2013976","journal-title":"Neurobiol Aging"},{"key":"9_CR29","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1083\/jcb.146.6.1239","volume":"146","author":"R. Garcia-Mata","year":"1999","unstructured":"Garcia-Mata R, Bebok Z, Sorscher EJ, Sztul ES (1999) Characterization and dynamics of aggresome formation by a cytosolic GFP-chimera. J Cell Biol 146:1239\u20131254","journal-title":"J Cell Biol"},{"key":"9_CR30","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/0022-2836(68)90014-4","volume":"32","author":"A.J. Geddes","year":"1968","unstructured":"Geddes AJ, Parker KD, Atkins ED, Beighton E (1968) \u201cCross-beta\u201d conformation in proteins. J Mol Biol 32:343\u2013358","journal-title":"J Mol Biol"},{"key":"9_CR31","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.tibs.2004.08.009","volume":"29","author":"C.G. Glabe","year":"2004","unstructured":"Glabe CG (2004) Conformation-dependent antibodies target diseases of protein misfolding. Trends Biochem Sci 29:542\u2013547","journal-title":"Trends Biochem Sci"},{"key":"9_CR32","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1152\/physrev.00027.2001","volume":"82","author":"M.H. Glickman","year":"2002","unstructured":"Glickman MH, Ciechanover A (2002) The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol Rev 82:373\u2013428","journal-title":"Physiol Rev"},{"key":"9_CR33","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0092-8674(00)81223-4","volume":"94","author":"J.R. Glover","year":"1998","unstructured":"Glover JR, Lindquist S (1998) Hsp104, Hsp70, and Hsp40: a novel chaperone system that rescues previously aggregated proteins. Cell 94:73\u201382","journal-title":"Cell"},{"key":"9_CR34","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1021\/bi00225a008","volume":"30","author":"M.E. Goldberg","year":"1991","unstructured":"Goldberg ME, Rudolph R, Jaenicke R (1991) A kinetic study of the competition between renaturation and aggregation during the refolding of denatured-reduced egg white lysozyme. Biochemistry 30:2790\u20132797","journal-title":"Biochemistry"},{"key":"9_CR35","first-page":"3","volume":"232","author":"N. Gregersen","year":"2003","unstructured":"Gregersen N, Bolund L, Bross P (2003) Protein misfolding, aggregation, and degradation in disease. Methods Mol Biol 232:3\u201316","journal-title":"Methods Mol Biol"},{"key":"9_CR36","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/381571a0","volume":"381","author":"F.U. Hartl","year":"1996","unstructured":"Hartl FU (1996) Molecular chaperones in cellular protein folding. Nature 381:571\u2013579","journal-title":"Nature"},{"key":"9_CR37","doi-asserted-by":"crossref","first-page":"8876","DOI":"10.1523\/JNEUROSCI.19-20-08876.1999","volume":"19","author":"D.M. Hartley","year":"1999","unstructured":"Hartley DM, Walsh DM, Ye CP et al (1999) Protofibrillar intermediates of amyloid betaprotein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons. J Neurosci 19:8876\u20138884","journal-title":"J Neurosci"},{"key":"9_CR38","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s000180300009","volume":"60","author":"C. Hetz","year":"2003","unstructured":"Hetz C, Soto C (2003) Protein misfolding and disease: the case of prion disorders. Cell Mol Life Sci 60: 133\u2013143","journal-title":"Cell Mol Life Sci"},{"key":"9_CR39","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.cell.2004.11.018","volume":"119","author":"A.L. Horwich","year":"2004","unstructured":"Horwich AL (2004) Chaperoned protein disaggregation-the ClpB ring uses its central channel. Cell 119: 579\u2013581","journal-title":"Cell"},{"key":"9_CR40","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1172\/JCI200216781","volume":"110","author":"A. Horwich","year":"2002","unstructured":"Horwich A (2002) Protein aggregation in disease: a role for folding intermediates forming specific multimeric interactions. J Clin Invest 110:1221\u20131232","journal-title":"J Clin Invest"},{"key":"9_CR41","first-page":"57","volume-title":"Prion diseases","author":"J.W. Ironside","year":"1997","unstructured":"Ironside JW, Bell JE (1997) Pathology of prion diseases In: Collinge J, Palmer MS (eds) Prion diseases. Oxford University Press, Oxford, pp 57\u201388"},{"key":"9_CR42","doi-asserted-by":"publisher","first-page":"9022","DOI":"10.1021\/bi034218k","volume":"42","author":"D. Ishimaru","year":"2003","unstructured":"Ishimaru D, Andrade LR, Teixeira LS et al (2003) Fibrillar aggregates of the tumour suppressor p53 core domain. Biochemistry 42:9022\u20139027","journal-title":"Biochemistry"},{"key":"9_CR43","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1098\/rstb.1995.0050","volume":"348","author":"R. Jaenicke","year":"1995","unstructured":"Jaenicke R (1995) Folding and association versus misfolding and aggregation of proteins. Philos Trans R Soc Lond B Biol Sci 348:97\u2013105","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"9_CR44","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1056\/NEJM199812313392707","volume":"339","author":"R.T. Johnson","year":"1998","unstructured":"Johnson RT, Gibbs CJ (1998) Creutzfeldt-Jakob disease and related transmissible spongiform encephalopathies. N Engl J Med 339:1994\u20132004","journal-title":"N Engl J Med"},{"key":"9_CR45","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s00018-003-3274-6","volume":"61","author":"J. Johansson","year":"2004","unstructured":"Johansson J, Weaver TE, Tjernberg LO (2004) Proteolytic generation and aggregation of peptides from transmembrane regions: lung surfactant protein C and amyloid betapeptide. Cell Mol Life Sci 61:326\u2013335","journal-title":"Cell Mol Life Sci"},{"key":"9_CR46","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1083\/jcb.143.7.1883","volume":"143","author":"J.A. Johnston","year":"1998","unstructured":"Johnston JA, Ward CL, Kopito RR (1998) Aggresomes: a cellular response to misfolded proteins. J Cell Biol 143:1883\u20131898","journal-title":"J Cell Biol"},{"key":"9_CR47","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1126\/science.1079469","volume":"300","author":"R. Kayed","year":"2003","unstructured":"Kayed R, Head E, Thompson JL et al (2003) Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300:486\u2013489","journal-title":"Science"},{"key":"9_CR48","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S0959-440X(98)80016-X","volume":"8","author":"J. Kelly","year":"1998","unstructured":"Kelly J (1998) Alternative conformation of amyloidogenic proteins and their multi-step assembly pathways. Curr Opin Struct Biol 8:101\u2013106","journal-title":"Curr Opin Struct Biol"},{"key":"9_CR49","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1038\/nbt0991-825","volume":"9","author":"T. Kiefhaber","year":"1991","unstructured":"Kiefhaber T, Rudolph R, Kohler H-H, Buchner J (1991) Protein aggregation in vitro and in vivo: a quantitative model of the kinetic competition between folding and aggregation. Nat Biotechnol 9:825\u2013829","journal-title":"Nat Biotechnol"},{"key":"9_CR50","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1083\/jcb.124.6.997","volume":"124","author":"C.M. Kielty","year":"1994","unstructured":"Kielty CM, Shuttleworth CA (1994) Abnormal fibrillin assembly by dermal fibroblasts from two patients with Marfan syndrome. J Cell Biol 124:997\u20131004","journal-title":"J Cell Biol"},{"key":"9_CR51","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/S0962-8924(00)01852-3","volume":"10","author":"R.R. Kopito","year":"2000","unstructured":"Kopito RR (2000) Aggresomes, inclusion bodies and protein aggregation. Trends Cell Biol 10:524\u2013530","journal-title":"Trends Cell Biol"},{"key":"9_CR52","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1093\/embo-reports\/kvd052","volume":"1","author":"R.R. Kopito","year":"2000","unstructured":"Kopito RR, Sitia R (2000) Aggresomes and Russell bodies. Symptoms of cellular indigestion? EMBO Rep 1: 225\u2013231","journal-title":"EMBO Rep"},{"key":"9_CR53","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1007\/s004390000393","volume":"107","author":"M. Krawczak","year":"2000","unstructured":"Krawczak M, Chuzhanova NA, Stenson PD et al (2000) Changes in primary DNA sequence complexity influence the phenotypic consequences of mutations in human gene regulatory regions. Hum Genet 107:362\u2013365","journal-title":"Hum Genet"},{"key":"9_CR54","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1002\/1531-8249(199912)46:6<842::AID-ANA6>3.0.CO;2-O","volume":"46","author":"S. Kuemmerle","year":"1999","unstructured":"Kuemmerle S, Gutekunst CA, Klein AM et al (1999) Huntington aggregates may not predict neuronal death in Huntington\u2019s disease. Ann Neurol 46:842\u2013849","journal-title":"Ann Neurol"},{"key":"9_CR55","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1002\/9783527619498.ch71","volume-title":"Protein folding handbook","author":"C. Lange","year":"2005","unstructured":"Lange C, Rudolph R (2005) Production of recombinant proteins for therapy, diagnostics, and industrial research by in vitro folding. In: Buchner J, Kiefhaber T (eds) Protein folding handbook. Vol. 3. Wiley, Weinheim, pp 1245\u20131280"},{"key":"9_CR56","doi-asserted-by":"publisher","first-page":"3342","DOI":"10.1073\/pnas.96.7.3342","volume":"96","author":"P.T. Lansbury","year":"1999","unstructured":"Lansbury PT (1999) Evolution of amyloid: what normal protein folding may tell us about fibrillogenesis and disease. Proc Natl Acad Sci U S A 96:3342\u20133344","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9_CR57","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S1568-1637(03)00025-4","volume":"2","author":"R. Layfield","year":"2003","unstructured":"Layfield R, Cavey JR, Lowe J (2003) Role of ubiquitin-mediated proteolysis in the pathogenesis of neurodegenerative disorders. Ageing Res Rep 2:343\u2013356","journal-title":"Ageing Res Rep"},{"key":"9_CR58","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jsb.2003.11.016","volume":"146","author":"S. Lee","year":"2004","unstructured":"Lee S, Sowa ME, Choi JM, Tsai FT (2004) The ClpB\/Hsp104 molecular chaperone-a protein disaggregating machine. J Struct Biol 146:99\u2013105","journal-title":"J Struct Biol"},{"key":"9_CR59","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/357605a0","volume":"357","author":"D.A. Lomas","year":"1992","unstructured":"Lomas DA, Evans DL, Finch JT, Carrell RW (1992) The mechanism of Z alpha 1-antitrypsin accumulation in the liver. Nature 357:605\u2013607","journal-title":"Nature"},{"key":"9_CR60","doi-asserted-by":"crossref","first-page":"12243","DOI":"10.1073\/pnas.91.25.12243","volume":"91","author":"A. Lorenzo","year":"1994","unstructured":"Lorenzo A, Yankner BA (1994) Beta-amyloid neurotoxicity requires fibril formation and is inhibited by Congo red. Proc Natl Acad Sci U S A 91:12243\u201312247","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9_CR61","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1096\/fasebj.14.5.769","volume":"14","author":"R. Mancini","year":"2000","unstructured":"Mancini R, Fagioli C, Fra AM, Maggioni C, Sitia R (2000) Degradation of unassembled soluble Ig subunits by cytosolic proteasomes: evidence that retro translocation and degradation are coupled events. FASEB J 14: 769\u2013778","journal-title":"FASEB J"},{"key":"9_CR62","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1749-6632.1998.tb08982.x","volume":"851","author":"A. Mathew","year":"1998","unstructured":"Mathew A, Morimoto RI (1998) Role of the heat-shock response in the life and death of proteins. Ann N Y Acad Sci 851:99\u2013111","journal-title":"Ann N Y Acad Sci"},{"key":"9_CR63","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0969-2126(04)00027-9","volume":"12","author":"M.R. Maurizi","year":"2004","unstructured":"Maurizi MR, Xia D (2004) Protein binding and disruption by Clp\/Hsp100 chaperones. Structure 12:175\u2013183","journal-title":"Structure"},{"key":"9_CR64","first-page":"239","volume":"94","author":"M. Mayer","year":"2004","unstructured":"Mayer M, Buchner J (2004) Refolding of inclusion body proteins. Methods Mol Med 94:239\u2013254","journal-title":"Methods Mol Med"},{"key":"9_CR65","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1002\/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M","volume":"46","author":"C.A. McLean","year":"1999","unstructured":"McLean CA, Cherny RA, Fraser FW et al (1999) Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer\u2019s disea. Ann Neurol 46:860\u2013866","journal-title":"Ann Neurol"},{"key":"9_CR66","first-page":"1065","volume":"39","author":"G. Merlini","year":"2001","unstructured":"Merlini G, Bellotti V, Andreola A et al (2001) Protein aggregation. Clin Chem Lab Med 39:1065\u20131075","journal-title":"Clin Chem Lab Med"},{"key":"9_CR67","doi-asserted-by":"publisher","first-page":"6934","DOI":"10.1093\/emboj\/18.24.6934","volume":"18","author":"A. Mogk","year":"1999","unstructured":"Mogk A, Tomoyasu T, Goloubinoff P et al (1999) Identification of thermolabile Escherichia coli proteins: prevention and reversion of aggregation by DnaK and ClpB. EMBO J 18:6934\u20136949","journal-title":"EMBO J"},{"key":"9_CR68","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1126\/science.6857241","volume":"220","author":"I. Nishio","year":"1983","unstructured":"Nishio I, Tanaka T, Sun ST et al (1983) Hemoglobin aggregation in single red blood cells of sickle cell anemia. Science 220:1173\u20131175","journal-title":"Science"},{"key":"9_CR69","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/S0968-0004(98)01350-4","volume":"24","author":"M.F. Perutz","year":"1999","unstructured":"Perutz MF (1999) Glutamine repeats and neurodegenerative diseases: molecular aspects. Trends Biochem Sci 24: 58\u201363","journal-title":"Trends Biochem Sci"},{"key":"9_CR70","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/00005072-199305000-00001","volume":"52","author":"M.S. Pollanen","year":"1993","unstructured":"Pollanen MS, Dickson DW, Bergeron C (1993) Pathology and biology of the Lewy body. J Neuropathol Exp Neurol 52:183\u2013191","journal-title":"J Neuropathol Exp Neurol"},{"key":"9_CR71","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/0145-2126(94)90020-5","volume":"18","author":"C. Preudhomme","year":"1994","unstructured":"Preudhomme C, Vachee A, Morschauser F et al (1994) Immunoglobulin and T-cell receptor delta gene rearrangements are rarely found in myelodysplastic syndromes in chronic phase. Leuk Res 18:365\u2013371","journal-title":"Leuk Res"},{"key":"9_CR72","doi-asserted-by":"publisher","first-page":"13363","DOI":"10.1073\/pnas.95.23.13363","volume":"95","author":"S.B. Prusiner","year":"1998","unstructured":"Prusiner SB (1998) Prions. Proc Natl Acad Sci U S A 95:13363\u201313383","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9_CR73","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1146\/annurev.genet.31.1.139","volume":"31","author":"S.B. Prusiner","year":"1997","unstructured":"Prusiner SB, Scott MR (1997) Genetics of prions. Annu Rev Genet 31:139\u2013175","journal-title":"Annu Rev Genet"},{"key":"9_CR74","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1105\/tpc.12.4.479","volume":"12","author":"C. Queitsch","year":"2000","unstructured":"Queitsch C, Hong SW, Vierling E, Lindquist S (2000) Heat shock protein 101 plays a crucial role in thermotolerance in Arabidopsis. Plant Cell 12:479\u2013492","journal-title":"Plant Cell"},{"key":"9_CR75","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/S0959-440X(99)00049-4","volume":"10","author":"J.C. Rochet","year":"2000","unstructured":"Rochet JC, Lansbury PT (2000) Amyloid fibrillogenesis: themes and variations. Curr Opin Struct Biol 10: 60\u201368","journal-title":"Curr Opin Struct Biol"},{"key":"9_CR76","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1038\/nm1066","volume":"10","author":"C.A. Ross","year":"2004","unstructured":"Ross CA, Poirier MA (2004) Protein aggregation and neurodegenerative disease. Nat Med 10 Suppl:S10\u2013S17","journal-title":"Nat Med"},{"issue":"[Suppl 4]","key":"9_CR77","doi-asserted-by":"crossref","first-page":"16412","DOI":"10.1073\/pnas.182426899","volume":"99","author":"H. Sakahira","year":"2002","unstructured":"Sakahira H, Breuer P, Hayer-Hartl MK, Hartl FU (2002) Molecular chaperones asmodulators of polyglutamine protein aggregation and toxicity. Proc Natl Acad Sci U S A 99[Suppl 4]:16412\u201316418","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9_CR78","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nature01301","volume":"421","author":"I. Sanchez","year":"2003","unstructured":"Sanchez I, Mahlke C, Yuan J (2003) Pivotal role of oligomerization in expanded polyglutamine neurodegenerative disorders. Nature 421:373\u2013379","journal-title":"Nature"},{"key":"9_CR79","doi-asserted-by":"publisher","first-page":"6005","DOI":"10.1093\/emboj\/cdf609","volume":"21","author":"A. Sandilands","year":"2002","unstructured":"Sandilands A, Hutcheson AM, Long HA et al (2002) Altered aggregation properties of mutant gamma-crystallins cause inherited cataract. EMBO J 21:6005\u20136014","journal-title":"EMBO J"},{"key":"9_CR80","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1385\/JMN:23:1-2:013","volume":"23","author":"T. Scheibel","year":"2004","unstructured":"Scheibel T (2004) Amyloid formation of a yeast prion determinant. J Mol Neurosci 23:13\u201322","journal-title":"J Mol Neurosci"},{"key":"9_CR81","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/9783527619498.ch39","volume-title":"Protein folding handbook","author":"T. Scheibel","year":"2005","unstructured":"Scheibel T, Serpell L (2005) Physical methods for studies of fibre formation and structure. In: Buchner J, Kiefhaber T (eds) Protein folding handbook. Vol. 3. Wiley, Weinheim, pp 197\u2013253"},{"key":"9_CR82","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/S0896-6273(03)00024-2","volume":"37","author":"R. Sharon","year":"2003","unstructured":"Sharon R, Bar-Joseph I, Frosch MP et al (2003) The formation of highly soluble oligomers of alpha-synuclein is regulated by fatty acids and enhanced in Parkinson\u2019s disease. Neuron 37:583\u2013595","journal-title":"Neuron"},{"key":"9_CR83","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0896-6273(01)00177-5","volume":"29","author":"M.Y. Sherman","year":"2001","unstructured":"Sherman MY, Goldberg AL (2001) Cellular defences against unfolded proteins: a cell biologist thinks about neurodegenerative diseases. Neuron 29:15\u201332","journal-title":"Neuron"},{"key":"9_CR84","doi-asserted-by":"publisher","first-page":":595","DOI":"10.1038\/35086072","volume":"2","author":"D.H. Small","year":"2001","unstructured":"Small DH, Mok SS, Bornstein JC (2001) Alzheimer\u2019s disease and Abeta toxicity: from top to bottom. Nat Rev Neurosci 2:595\u2013598","journal-title":"Nat Rev Neurosci"},{"key":"9_CR85","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1023\/A:1010082129022","volume":"1","author":"C. Soti","year":"2000","unstructured":"Soti C, Csermely P (2000) Molecular chaperones and the aging process. Biogerontology 1:225\u2013233","journal-title":"Biogerontology"},{"key":"9_CR86","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1038\/nbt1096-1283","volume":"14","author":"M.A. Speed","year":"1996","unstructured":"Speed MA, Wang DIC, King J (1996) Specific aggregation of partially folded polypeptide chains-the molecular basis of inclusion body composition. Nat Biotechnol 14:1283\u20131287","journal-title":"Nat Biotechnol"},{"key":"9_CR87","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/sj.embor.embor869","volume":"4","author":"P.C. Stirling","year":"2003","unstructured":"Stirling PC, Lundin VF, Leroux MR (2003) Getting a grip on non-native proteins. EMBO Rep 4:565\u2013570","journal-title":"EMBO Rep"},{"key":"9_CR88","doi-asserted-by":"publisher","first-page":"39020","DOI":"10.1074\/jbc.M303625200","volume":"278","author":"A. Stojanovic","year":"2003","unstructured":"Stojanovic A, Hwang I, Khorana HG, Hwa J (2003) Retinitis pigmentosa rhodopsin mutations L125R and A164 V perturb critical interhelical interactions: new insights through compensatory mutations and crystal structure analysis. J Biol Chem 278:39020\u201339028","journal-title":"J Biol Chem"},{"key":"9_CR89","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0065-3233(08)60320-4","volume":"50","author":"M. Sunde","year":"1997","unstructured":"Sunde M, Blake C (1997) The structure of amyloid fibrils by electron microscopy and X-ray diffraction. Adv Protein Chem 50:123\u2013159","journal-title":"Adv Protein Chem"},{"key":"9_CR90","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1126\/science.1067122","volume":"296","author":"J.P. Taylor","year":"2002","unstructured":"Taylor JP, Hardy J, Fischbeck KH (2002) Toxic proteins in neurodegenerative disease. Science 296: 1991\u20131995","journal-title":"Science"},{"key":"9_CR91","doi-asserted-by":"crossref","first-page":"4299","DOI":"10.1073\/pnas.92.10.4299","volume":"92","author":"G.A. Tennent","year":"1995","unstructured":"Tennent GA, Lovat LB, Pepys MB (1995). Serum amyloid P component prevents proteolysis of the amyloid fibrils of Alzheimer disease and systemic amyloidosis. Proc Natl Acad Sci U S A 92:4299\u20134303","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9_CR92","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3109\/13506129808995290","volume":"5","author":"D.B. Teplow","year":"1998","unstructured":"Teplow DB (1998) Structural and kinetic features of amyloid beta-protein fibrillogenesis. Amyloid 5: 121\u2013142","journal-title":"Amyloid"},{"key":"9_CR93","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1002\/ana.410300410","volume":"30","author":"R.D. Terry","year":"1991","unstructured":"Terry RD, Masliah E, Salmon DP et al (1991) Physical basis of cognitive alterations in Alzheimer\u2019s disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 30:572\u2013580","journal-title":"Ann Neurol"},{"key":"9_CR94","doi-asserted-by":"publisher","first-page":"17014","DOI":"10.1073\/pnas.252523899","volume":"99","author":"A.K. Thakur","year":"2002","unstructured":"Thakur AK, Wetzel R (2002) Mutational analysis of the structural organization of polyglutamine aggregates. Proc Natl Acad Sci U S A 99:17014\u201317019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9_CR95","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1083\/jcb.111.2.329","volume":"111","author":"J. Tooze","year":"1990","unstructured":"Tooze J, Hollinshead M, Ludwig T et al (1990) In exocrine pancreas, the basolateral endocytic pathway converges with the autophagic pathway immediately after the early endosome. J Cell Biol 111:329\u2013345","journal-title":"J Cell Biol"},{"key":"9_CR96","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1007\/s00018-003-3096-6","volume":"60","author":"V.N. Uversky","year":"2003","unstructured":"Uversky VN (2003) Protein folding revisited. A polypeptide chain at the folding-misfolding-non folding cross-roads: which way to go? Cell Mol Life Sci. 60:1852\u20131871","journal-title":"Cell Mol Life Sci."},{"key":"9_CR97","doi-asserted-by":"crossref","first-page":"43495","DOI":"10.1074\/jbc.C100551200","volume":"276","author":"V.N. Uversky","year":"2001","unstructured":"Uversky VN, Lee HJ, Li J et al (2001) Stabilisation of partially folded conformation during alpha synuclein oligomerization in both purified and cytosolic preparations. J Biol Chem 276:43495\u201343498","journal-title":"J Biol Chem"},{"key":"9_CR98","doi-asserted-by":"publisher","first-page":"7812","DOI":"10.1021\/bi0102398","volume":"40","author":"M.J. Volles","year":"2001","unstructured":"Volles MJ, Lee SJ, Rochet JC et al (2001) Vesicle permeabilization by protofibrillar alphasynuclein: implications for the pathogenesis and treatment of Parkinson\u2019s disease. Biochemistry 40:7812\u20137819","journal-title":"Biochemistry"},{"key":"9_CR99","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1002\/1521-3773(20020402)41:7<1098::AID-ANIE1098>3.0.CO;2-9","volume":"41","author":"S. Walter","year":"2002","unstructured":"Walter S, Buchner J (2002) Molecular chaperones-cellular machines for protein folding. Angew Chem Int Ed Engl 41:1098\u20131113","journal-title":"Angew Chem Int Ed Engl"},{"key":"9_CR100","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1515\/BC.2000.114","volume":"381","author":"E.E. Wanker","year":"2000","unstructured":"Wanker EE (2000) Protein aggregation and pathogenesis of Huntington\u2019s disease: mechanisms and correlations. Biol Chem 381:937\u2013942","journal-title":"Biol Chem"},{"key":"9_CR101","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1126\/science.1070925","volume":"296","author":"A. Weihofen","year":"2002","unstructured":"Weihofen A, Binns K, Lemberg MK et al (2002) Identification of signal peptide peptidase, a presenilin-type aspartic protease. Science 296:2215\u20132218","journal-title":"Science"},{"key":"9_CR102","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/35056563","volume":"2","author":"A.M. Weissman","year":"2001","unstructured":"Weissman AM (2001) Themes and variations on ubiquitylation. Nat Rev Mol Cell Biol 2:169\u2013178","journal-title":"Nat Rev Mol Cell Biol"},{"key":"9_CR103","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1083\/jcb.145.3.481","volume":"145","author":"W.C. Wigley","year":"1999","unstructured":"Wigley WC, Fabunmi RP, Lee MG et al (1999) Dynamic association of proteasomal machinery with the centrosome. J Cell Biol 145:481\u2013490","journal-title":"J Cell Biol"},{"key":"9_CR104","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1006\/jmbi.1996.0343","volume":"259","author":"H. Wille","year":"1996","unstructured":"Wille H, Zhang GF, Baldwin MA et al (1996) Separation of scrapie prion infectivity from PrP amyloid polymers. J Mol Biol 259:608\u2013621","journal-title":"J Mol Biol"},{"key":"9_CR105","doi-asserted-by":"crossref","first-page":"9014","DOI":"10.1073\/pnas.91.19.9014","volume":"91","author":"Y. Wu","year":"1994","unstructured":"Wu Y, Whitman I, Molmenti E et al (1994) A lag in intracellular degradation ofmutant alpha 1-antitrypsin correlates with the liver disease phenotype in homozygous PiZZ alpha 1-antitrypsin deficiency. Proc Natl Acad Sci U S A 91: 9014\u20139018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9_CR106","doi-asserted-by":"crossref","first-page":"9020","DOI":"10.1073\/pnas.87.22.9020","volume":"87","author":"B.A. Yankner","year":"1990","unstructured":"Yankner BA, Caceres A, Duffy LK (1990) Nerve growth factor potentiates the neurotoxicity of beta amyloid. Proc Natl Acad Sci U S A 87:9020\u20139023","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9_CR107","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/nature01071","volume":"419","author":"T. Yao","year":"2002","unstructured":"Yao T, Cohen RE (2002) A cryptic protease couples deubiquitination and degradation by the proteasome. Nature 419:403\u2013407","journal-title":"Nature"},{"key":"9_CR108","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1083\/jcb.200110119","volume":"156","author":"Y. Zhang","year":"2002","unstructured":"Zhang Y, McLaughlin R, Goodyer C, LeBlanc A (2002) Selective cytotoxicity of intracellular amyloid beta peptide1-42 through p53 and Bax in cultured primary human neurons. J Cell Biol 156:519\u2013529","journal-title":"J Cell Biol"},{"key":"9_CR109","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/S0168-9525(02)02729-4","volume":"18","author":"H.Y. Zoghbi","year":"2002","unstructured":"Zoghbi HY, Botas J (2002) Mouse and fly models of neurodegeneration. Trends Genet 18:463\u2013471","journal-title":"Trends Genet"},{"key":"9_CR110","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0065-3233(01)59006-3","volume":"59","author":"P. Zwickl","year":"2001","unstructured":"Zwickl P, Seemuller E, Kapelari B, Baumeister W (2001) The proteasome: a supramolecular assembly designed for controlled proteolysis. Adv Protein Chem 59:187\u2013222","journal-title":"Adv Protein Chem"}],"container-title":["Handbook of Experimental Pharmacology","Molecular Chaperones in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/3-540-29717-0_9.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T17:57:40Z","timestamp":1619546260000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/3-540-29717-0_9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[null]]},"ISBN":["3540258752"],"references-count":110,"URL":"https:\/\/doi.org\/10.1007\/3-540-29717-0_9","relation":{},"subject":[]}}